ATE245655T1 - Organische-arsenverbindungen - Google Patents

Organische-arsenverbindungen

Info

Publication number
ATE245655T1
ATE245655T1 AT00919444T AT00919444T ATE245655T1 AT E245655 T1 ATE245655 T1 AT E245655T1 AT 00919444 T AT00919444 T AT 00919444T AT 00919444 T AT00919444 T AT 00919444T AT E245655 T1 ATE245655 T1 AT E245655T1
Authority
AT
Austria
Prior art keywords
arsenic compounds
organic arsenic
cancer cells
cells
regard
Prior art date
Application number
AT00919444T
Other languages
English (en)
Inventor
Fatih M Uckun
Xing-Ping Liu
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Application granted granted Critical
Publication of ATE245655T1 publication Critical patent/ATE245655T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00919444T 1999-03-19 2000-03-16 Organische-arsenverbindungen ATE245655T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12533799P 1999-03-19 1999-03-19
US09/338,680 US6191123B1 (en) 1999-03-19 1999-06-23 Organic-arsenic compounds
PCT/US2000/007063 WO2000056742A1 (en) 1999-03-19 2000-03-16 Organic-arsenic compounds

Publications (1)

Publication Number Publication Date
ATE245655T1 true ATE245655T1 (de) 2003-08-15

Family

ID=26823484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919444T ATE245655T1 (de) 1999-03-19 2000-03-16 Organische-arsenverbindungen

Country Status (8)

Country Link
US (3) US6191123B1 (de)
EP (1) EP1163246B1 (de)
JP (1) JP2002540114A (de)
AT (1) ATE245655T1 (de)
AU (1) AU4013400A (de)
CA (1) CA2365201A1 (de)
DE (1) DE60004027T2 (de)
WO (1) WO2000056742A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
GB0128405D0 (en) * 2001-11-27 2002-01-16 Btg Int Ltd Process for fabricating polyolefin sheet
US20030135041A1 (en) * 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
EP1474128B1 (de) 2002-01-07 2016-06-01 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinsäure,s-dimethylarsino-2-thiobenzoesäure, s-(dimethylarsino)-glutathion zur krebsbehandlung
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
EP1563099B1 (de) 2002-11-07 2009-07-22 Newsouth Innovations Pty Limited Induktion der mitochondrialen permeabilitätstransition
US6686344B1 (en) 2003-01-30 2004-02-03 Paker Hughes Institute Organic-arsonic compounds
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
JP4994374B2 (ja) * 2005-07-29 2012-08-08 ジオファーム オンコロジー， インコーポレイテッド がんを治療するための化合物および方法
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
EP2069371B1 (de) 2006-11-01 2013-03-13 NewSouth Innovations Pty Limited Organo-arsenoxid-verbindungen und deren verwendung
CN101903029B (zh) * 2007-11-02 2012-09-26 Zio医药肿瘤学公司 使用有机砷化物的联合治疗
WO2009075870A1 (en) * 2007-12-12 2009-06-18 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
PT2321012T (pt) 2008-08-20 2019-01-11 Solasia Pharma K K Compostos organoarsénicos e métodos para o tratamento de cancro
TWI461410B (zh) 2008-12-30 2014-11-21 Arqule Inc 經取代之５，６－二氫－６－苯基苯並〔f〕異喹啉－２－胺化合物類

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017380A (en) * 1958-12-05 1962-01-16 Dal Mon Research Co Aldehyde-triazinyl arsenic condensation products and method of making same
SU977461A1 (ru) * 1981-04-28 1982-11-30 Ордена Ленина Институт Геохимии И Аналитической Химии Им.В.И.Вернадского Способ получени 2,7-бис-(2-арсонофенилазо)-1,8-диоксинафталин-3,6-дисульфокислоты (арсеназо ш)
FR2640269B1 (fr) * 1988-12-13 1991-03-15 Maes Ludo Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
FR2684382B1 (fr) * 1991-12-02 1994-10-21 Rhone Merieux Medicaments et preparations pures de dichlorhydrate de melarsomine, leur procede d'obtention et produits intermediaires obtenus.
AU4241196A (en) * 1994-11-30 1996-06-19 University Hospital, The Compositions for the treatment of parasitic and fungal infections
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds

Also Published As

Publication number Publication date
AU4013400A (en) 2000-10-09
DE60004027D1 (de) 2003-08-28
US6482815B1 (en) 2002-11-19
EP1163246A1 (de) 2001-12-19
WO2000056742A9 (en) 2001-11-01
JP2002540114A (ja) 2002-11-26
EP1163246B1 (de) 2003-07-23
US6482816B1 (en) 2002-11-19
WO2000056742A1 (en) 2000-09-28
CA2365201A1 (en) 2000-09-28
DE60004027T2 (de) 2004-04-22
US6191123B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DE60004027D1 (de) Organische-arsenverbindungen
YU52099A (sh) Fungicidni trifluormetilalkilamino-triazolpirimidini
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
BR0210471A (pt) Ligandos do receptor 5-ht e suas utilizações
DK1200412T3 (da) Antiproliferative imidazolforbindelser
GB0119249D0 (en) Organic compounds
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
CO4340688A1 (es) Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos.
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
UY3402Q (es) Diseno de tractor
BR9916833A (pt) Derivados de epotilona e seu uso como agentes antitumor
WO2006020048A3 (en) Compounds and methods for treatment of cancer
HN2000000003A (es) Antibioticos cetolidos
ECSP066549A (es) Compuestos de pirazolilo e imidazolilo bicíclicos y usos de los mismos
WO2005007103A3 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
ECSP055863A (es) Piridodiacinas como funguicidas de plantas
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
ATE299505T1 (de) Fungizide 6-(2-halo-4-alkoxyphenyl)- triazolopyrimidine
PT1212311E (pt) Cumarinas de calcona
ATE250603T1 (de) 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung
ZA200502790B (en) Extract with anti-tumor and anti-poisonous activity.
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse
ECSP003761A (es) Compuestos heterociclicos sililados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties